Arrhythmias & electrophysiology

Antiarrhythmic drugs vs catheter ablation as rhythm control for atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials

Heart RhythmPublished systematic review

Authors' conclusion

This review found that, in some subgroups of patients, catheter ablation was better than AAD treatment when considering AF recurrence and mortality. However, catheter ablation has rare but serious complications that should be considered when making informed treatment decisions.

Study context

Population
Patients with atrial fibrillation (AF) treated for rhythm control22 studies (31 references) included in the review
Comparison
Treated with anti-arrhythmic drugs (AAD) compared with catheter ablation
Outcome
Recurrence of AF
Methodological detailsupdate of a National Institute for Health and Care Excellence (2021) systematic review, Cochrane Risk of Bias 2 tool, Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach
  • Update of a National Institute for Health and Care Excellence (2021) systematic review
  • Cochrane Risk of Bias 2 tool
  • GRADE approach

Pooled result

As reported in the abstract

AAD vs catheter ablationRelative risk (95% CI)
Treatment-naïve paroxysmal AF
1.76(1.34–2.32)
AAD-exposed persistent AF
1.62(1.40–1.87)
Paroxysmal AF previously exposed to catheter ablation
2.12(1.61–2.80)

Further pooled results

OutcomeRR (95% CI)
All-cause mortalityAADvs catheter ablationParoxysmal AF1.79 (0.80–4.02)
All-cause mortalityAADvs catheter ablationPersistent AF1.45 (0.56–3.75)

Safety

Medication side effects, including gastrointestinal symptoms and syncope — AAD
incidence between 0.8 and 3%
Catheter ablation complications, such as pericardial tamponade and phrenic nerve paralysis
between 0.3 and 2.5% · incidence

Original publication

Antiarrhythmic drugs vs catheter ablation as rhythm control for atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. Published 23 March 2026. doi:10.1016/j.hrthm.2026.03.1886

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.